SHARP DECREASE IN HCV-SPECIFIC INTERFERON-γ AND IL-10 PRODUCTION DURING ANTIVIRAL THERAPY WITH PEGYLATED INTERFERON AND RIBAVIRIN PREDICT SUSTAINED VIROLOGICAL RESPONSE IN CHILDREN WITH CHRONIC HEPATITIS C

被引：0
|
作者：
Carey, Ivana [1 ]
Mendes, Andrea [1 ]
Bansal, Sanjay [1 ]
Subramaniam, Pushpa [1 ]
Longhi, Maria Serena [1 ]
Cebecauerova, Dita [1 ]
Mieli-Vergani, Giorgina [1 ]
Vergani, Diego [1 ]
机构：
[1] Kings Coll Hosp London, Inst Liver Studies, Kings Coll London Sch Med, London SE5 8RX, England
来源：
HEPATOLOGY | 2009年 / 50卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
702
引用
收藏
页码：634A / 634A
页数：1
相关论文
共 50 条
  • [1] HCV-specific production of IL-10 and IFN-gamma-inducible protein-10 (IP-10) levels predict treatment response to pegylated interferon and ribavirin in children with chronic hepatitis C infection
    Carey, Ivana
    Mytilinaiou, Maria
    Hussain, Munther
    Bansal, Sanjay
    Subramaniam, Pushpa
    Horner, Mary
    Longhi, Maria Serena
    Meda, Francesca
    Mieli-Vergani, Giorgina
    Vergani, Diego
    [J]. HEPATOLOGY, 2007, 46 (04) : 279A - 279A
  • [2] LOW NK CELL NUMBER, LOW HCV-SPECIFIC IL-10 PRODUCTION AND HIGH CD56BRIGHT CELL NUMBER PREDICT RESPONSE TO PEGYLATED-INTERFERON/RIBAVIRIN THERAPY IN CHRONIC HEPATITIS C IN CHILDREN
    Carey, I.
    Mendes, A.
    Cebecauerova, D.
    Bansal, S.
    Subramaniam, P.
    Tizzard, S.
    Mieli-Vergani, G.
    Vergani, D.
    [J]. JOURNAL OF HEPATOLOGY, 2010, 52 : S176 - S177
  • [3] On Treatment Weight Loss as a Predictor of Sustained Virological Response During Pegylated Interferon and Ribavirin Therapy for Chronic Hepatitis C
    Dhavaleshwar, Deepti
    Babich, Michael
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 : S108 - S108
  • [4] LOW PRE-TREATMENT NUMBERS OF CD4+/PD-1+LYMPHOCYTES AND LOW HCV-SPECIFIC IL-10 PRODUCTION DURING THERAPY WITH PEGYLATED-INTERFERON plus RIBAVIRIN PREDICT RESPONSE IN CHILDREN WITH CHRONIC HEPATITIS C
    Carey, I.
    Bansal, S.
    Mendes, A.
    Subramaniam, P.
    Cebecauerova, D.
    Vergani, D.
    Mieli-Vergani, G.
    [J]. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2010, 50 : E17 - E17
  • [5] LOW PRE-TREATMENT NUMBERS OF CD4+/PD1+LYMPHOCYTES AND LOW HCV-SPECIFIC IL-10 PRODUCTION DURING THERAPY WITH PEGYLATED-INTERFERON plus RIBAVIRIN PREDICT RESPONSE IN CHILDREN WITH CHRONIC HEPATITIS C
    Carey, I.
    Mendes, A.
    Cebecauerova, D.
    Bansal, S.
    Subramaniam, P.
    Tizzard, S.
    Mieli-Vergani, G.
    Vergani, D.
    [J]. JOURNAL OF HEPATOLOGY, 2010, 52 : S266 - S266
  • [6] PREDICTORS OF SUSTAINED VIROLOGICAL RESPONSE IN PATIENTS WITH CHRONIC HEPATITIS C TREATED WITH PEGYLATED INTERFERON AND RIBAVIRIN
    Paci, M.
    Lorefice, E.
    Gianni, E.
    Renzo, S.
    Capanni, M.
    Forte, P.
    Milani, S.
    Surrenti, C.
    [J]. DIGESTIVE AND LIVER DISEASE, 2008, 40 : S113 - S113
  • [7] Early virological response in children with chronic hepatitis C treated with pegylated interferon and ribavirin
    Kowala-Piaskowska, A.
    Sluzewski, W.
    Figlerowicz, M.
    Mozer-Lisewska, I.
    [J]. INFECTION, 2007, 35 (03) : 175 - 179
  • [8] Early Virological Response in Children with Chronic Hepatitis C Treated with Pegylated Interferon and Ribavirin
    A. Kowala-Piaskowska
    W. Służewski
    M. Figlerowicz
    I. Mozer-Lisewska
    [J]. Infection, 2007, 35
  • [9] Pegylated Interferon-α Plus Ribavirin Therapy Improves Left Ventricular Diastolic Dysfunction in Patients With Chronic Hepatitis C Attaining Sustained Virological Response
    Mohammed, Abdul-Quddus
    Auckle, Ranshaka
    Li, Hai-Ling
    Xu, Si-Ling
    Liu, Lu
    Zhao, Dong-Dong
    Che, Wen-Liang
    [J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2018, 355 (06): : 566 - 572
  • [10] Impact of ribavirin plasma level on sustained virological response in patients treated with pegylated interferon and ribavirin for chronic hepatitis C
    Breilh, D.
    Foucher, J.
    Castera, L.
    Trimoulet, P.
    Djabarouti, S.
    Merrouche, W.
    Couzigou, P.
    Saux, M. -C.
    De Ledinghen, V.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2009, 30 (05) : 487 - 494
12345